Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Josep Maria M. Piulats, MD, PhD
Dr. Piulats’s project is focused on the development of a new cellular therapy against uveal melanoma (UM)…. -
CRI Funded Scientist
Catalina Lee Chang, PhD
Immunotherapy has transformed cancer treatment, but its success has not yet been fully realized for brain tumors…. -
CRI Funded Scientist
Lloyd Bod, PhD
Dr. Bod’s research focuses on understanding immune checkpoint receptors on B cells and it can have important… -
CRI Funded Scientist
Matteo Maria Bellone, MD
Multiple myeloma (MM) is an incurable medical condition where abnormal plasma cells in the bone marrow (BM)… -
CRI Funded Scientist
Elisabeth M Battinelli, MD, PhD
The aim of Dr. Battinelli’s research is to demonstrate that cancer patients would benefit from the addition… -
CRI Funded Scientist
Md Torikul Islam, PhD
Osteosarcoma is the most common and deadly form of bone cancer that affects children and adolescents. The… -
CRI Funded Scientist
Valsamo Anagnostou, MD, PhD
To address unmet needs, Dr. Anagnostou proposes to study the evolving ecosystem of gastroesophageal cancer during immune… -
CRI Funded Scientist
Giulia Furesi, PhD
Dr. Furesi aims to characterize Osterix (Osx, a protein)-expressing cells and investigate the mechanisms by which Osx… -
CRI Funded Scientist
Camillia S. Azimi, PhD
Despite significant advancements in cancer immunotherapy, solid tumors, which constitute about 90% of adult cancer cases, remain…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.